间充质干细胞
微泡
胞外囊泡
间质细胞
外体
细胞外小泡
细胞生物学
体外
体内
细胞
化学
小RNA
纳米技术
生物医学工程
材料科学
医学
生物
癌症研究
生物化学
生物技术
基因
作者
Daniel Levy,Anjana Jeyaram,Louis J. Born,Kyungho Chang,Sanaz Nourmohammadi Abadchi,Angela Ting Wei Hsu,Talia Solomon,Amaya Aranda,Samantha Stewart,Xiaoming He,John W. Harmon,Steven M. Jay
出处
期刊:Cytotherapy
[Elsevier]
日期:2022-12-10
卷期号:25 (5): 502-509
被引量:17
标识
DOI:10.1016/j.jcyt.2022.11.006
摘要
Background aims As evidenced by ongoing clinical trials and increased activity in the commercial sector, extracellular vesicle (EV)-based therapies have begun the transition from bench to bedside. As this progression continues, one critical aspect of EV clinical translation is understanding the effects of storage and transport conditions. Several studies have assessed the impact of storage on EV characteristics such as morphology, uptake and component content, but effects of storage duration and temperature on EV functional bioactivity and, especially, loaded cargo are rarely reported. Methods The authors assessed EV outcomes following storage at different temperatures (room temperature, 4°C, –20°C, –80°C) for various durations as well as after lyophilization. Results Mesenchymal stromal cell (MSC) EVs were observed to retain key aspects of their bioactivity (pro-vascularization, anti-inflammation) for up to 4–6 weeks at –20°C and –80°C and after lyophilization. Furthermore, via in vitro assays and an in vivo wound healing model, these same storage conditions were also demonstrated to enable preservation of the functionality of loaded microRNA and long non-coding RNA cargo in MSC EVs. Conclusions These findings extend the current understanding of how EV therapeutic potential is impacted by storage conditions and may inform best practices for handling and storing MSC EVs for both basic research and translational purposes.
科研通智能强力驱动
Strongly Powered by AbleSci AI